In young women identified with a BRCA1 or BRCA2 mutation, RRS is performed in an effort to reduce ovarian cancer risk while maintaining adequate hormonal levels to avoid the effects of early menopause. This evidence concerns the gene BRCA2 and ovarian carcinoma.